Guidelines for Diagnosis and Treatment of Primary Myelofibrosis in China (2019 Edition)
Click the blue text Follow us Primary myelofibrosis (PMF) has made significant progress in diagnosis and treatment in recent years, such as updates to the WHO diagnostic criteria, new clinical trial data for ruxolitinib, and its market approval in China. To provide standardized clinical practice guidance for hematology doctors in China regarding PMF, the Leukemia … Read more